Veeva Systems (VEEV) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Veeva Systems

NYSE•Healthcare•Health Information Services

$266.62+0.95(<0.01%)Pre-market

Market Cap

$42.82B

P/E

42.2x

P/S

12.4x

P/B

5.8x

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

How this company scores

ExcellentMetricSide Score: 82/100

Strongest: Growth (24/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability20/25

Growth24/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality23/25

Strengths

Growing revenueRising free cash flowStrong marginsRising earnings

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 42.2x5y range 27.4x – 120.0x

Currently near its 20-quarter median.

P/S · 12.4x5y range 7.5x – 30.6x

Currently near its 20-quarter median.

P/B · 5.8x5y range 3.5x – 19.4x

Price & Volume

Market Cap $42.82B

Metrics at a Glance

as of July 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.46B
Q. Revenue: $927.96M
TTM EBITDA: $1.03B
TTM Op. Income: $1.03B
Q. Op. Income: $275.02M
TTM Net Income: $1.01B
Q. Net Income: $273.43M
EPS: $1.68
Shares Out.: $162.34M

$3.46B in TTM revenue grew 16.5% YoY, reaching $927.96M last quarter. TTM EBITDA of $1.03B and TTM operating income of $1.03B show growth is flowing through to the bottom line. TTM net income of $1.01B means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 75.0%
EBITDA Margin: 29.6%
Op. Margin: 29.6%
Net Margin: 29.5%

Op. margin of 29.6% is up 4.8% YoY — cost efficiency is improving. Net margin at 29.5% and gross margin of 75.0% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 19% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 42.2x
P/S Ratio: 12.4x
P/B Ratio: 5.8x

At 42.2x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 12.4x and P/B of 5.8x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 27% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $9.06B
Cash: $1.81B
Long-Term Debt: N/A
Book Value: $7.43B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $238.71M
TTM Free Cash Flow: $1.67B
FCF Margin: 48.2%
FCF / Net Income: 1.6

TTM FCF of $1.67B on $238.71M in operating cash flow. The FCF / Net Income ratio of 1.6x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 7 consecutive quarters — an improving trend.